RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $183,000 | +4.0% | 61,175 | -8.1% | 0.01% | +16.7% |
| Q4 2021 | $176,000 | -71.0% | 66,586 | -60.2% | 0.01% | -68.4% |
| Q3 2021 | $607,000 | +3.8% | 167,227 | +24.1% | 0.02% | +35.7% |
| Q2 2021 | $585,000 | +26.9% | 134,724 | 0.0% | 0.01% | +27.3% |
| Q1 2021 | $461,000 | -18.8% | 134,724 | -17.0% | 0.01% | -8.3% |
| Q4 2020 | $568,000 | +35.6% | 162,353 | -6.9% | 0.01% | +33.3% |
| Q3 2020 | $419,000 | +87.1% | 174,470 | +42.7% | 0.01% | +80.0% |
| Q2 2020 | $224,000 | – | 122,252 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |